List of Tables:
Table 8-1: Collaboration Deals in the Cancer Vaccines Market
Table 8-2: Licensing Agreement in the Cancer Vaccines Market
Table 8-3: Partnership Deals in the Cancer Vaccines Market
Table 8-4: Merger & Acquisitions in the Cancer Vaccines Market
Table 9-1: United States - Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 9-2: European Union - Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 9-3: Japan - Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 11-1: Genocea Biosciences, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-2: GeoVax, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-3: Moderna, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-4: Northwest Biotherapeutics, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-5: OncBioMune Pharmaceuticals, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-6: Inovio Pharmaceuticals, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-7: Enochian Biosciences Promising Cancer Vaccines in the Clinical Development
Table 11-8: Flow Pharma, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-9: Polynoma LLC Promising Cancer Vaccines in the Clinical Development
Table 11-10: IO Biotech Promising Cancer Vaccines in the Clinical Development
Table 11-11: Eu Biologics Co., Ltd. Promising Cancer Vaccines in the Clinical Development
Table 11-12: OncoPep Promising Cancer Vaccines in the Clinical Development
Table 11-13: Medigen, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-14: EVOQ Therapeutics Promising Cancer Vaccines in the Clinical Development
Table 11-15: Heat Biologics, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-16: Vicinivax Promising Cancer Vaccines in the Clinical Development
Table 11-17: ImmuneTune Promising Cancer Vaccines in the Clinical Development
Table 11-18: Elios Therapeutics Promising Cancer Vaccines in the Clinical Development
Table 11-19: Treos Bio Limited Promising Cancer Vaccines in the Clinical Development
Table 11-20: Scancell Holdings PLC Promising Cancer Vaccines in the Clinical Development
Table 11-21: EpiThany Promising Cancer Vaccines in the Clinical Development
Table 11-22: CureVac AG Promising Cancer Vaccines in the Clinical Development
Table 11-23: DCprime Promising Cancer Vaccines in the Clinical Development
Table 11-24: Vaximm AG Promising Cancer Vaccines in the Clinical Development
Table 11-25: Anixa Biosciences, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-26: AdaptVac Promising Cancer Vaccines in the Clinical Development
Table 11-27: PDC*line Pharma Promising Cancer Vaccines in the Clinical Development
Table 11-28: MimiVax LLC Promising Cancer Vaccines in the Clinical Development
Table 11-29: Agenus, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-30: AlphaVax Promising Cancer Vaccines in the Clinical Development
Table 11-31: Genexine Promising Cancer Vaccines in the Clinical Development
Table 11-32: GlobeImmune, Inc Promising Cancer Vaccines in the Clinical Development
Table 11-33: Ubivac Promising Cancer Vaccines in the Clinical Development
Table 11-34: Vaccinogen Promising Cancer Vaccines in the Clinical Development
Table 11-35: OSE Immunotherapeutics Promising Cancer Vaccines in the Clinical Development
List of Figures:
Figure 4-1: Global Cancer Vaccines Market Size (Million US$), 2015 - 2019
Figure 4-2: Global Cancer Vaccines Market Forecast (Million US$), 2020 - 2025
Figure 5-1: Gardasil/Gardasil 9 Market Value Analysis (Million US$), 2015 - 2019
Figure 5-2: Gardasil/Gardasil 9 Market Value Forecast (Million US$), 2020 - 2025
Figure 5-3: Cervarix Market Value Analysis (Million US$), 2015 - 2019
Figure 5-4: Cervarix Market Value Forecast (Million US$), 2020 - 2025
Figure 5-5: Provenge Market Value Analysis (Million US$), 2015 - 2019
Figure 5-6: Provenge Market Value Forecast (Million US$), 2020 - 2025
Figure 5-7: Imlygic Market Value Analysis (Million US$), 2016 - 2019
Figure 5-8: Imlygic Market Value Forecast (Million US$), 2020 - 2025
LIST OF FIGURE
